phospho-DDR1 (Tyr513) Polyclonal Antibody

$HepG2 cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

HepG2 cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

$Lane 1: K562 cell lysates; Lane 2: Siha cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: K562 cell lysates; Lane 2: Siha cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

$Lane 1: HepG2 cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: HepG2 cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

$Lane 1: K562 cell lysates; Lane 2: Hela cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: K562 cell lysates; Lane 2: Hela cell lysates probed with MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u02daC overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

$Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Rat Cerebrum tissue lysates; Lane 3: Human MCF-7 cell lysates; Lane 4: Human K562 cell lysates; Lane 5: Human A431 cell lysates; Lane 6: Human HeLa cell lysates probed with phospho-MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Rat Cerebrum tissue lysates; Lane 3: Human MCF-7 cell lysates; Lane 4: Human K562 cell lysates; Lane 5: Human A431 cell lysates; Lane 6: Human HeLa cell lysates probed with phospho-MCK10 (Tyr513) Polyclonal Antibody, Unconjugated (bs-6269R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

Applications

WB
ELISA
IHC-P
IHC-F
IF(IHC-P)
IF(IHC-F)
IF(ICC)

Reactivity

Human
Mouse
Rat

Predicted Reactivity

Cow
Pig
Horse

Overview
Catalog #	bs-6269R
Product Name	phospho-DDR1 (Tyr513) Polyclonal Antibody
Applications	WB ELISA IHC-P IHC-F IF(IHC-P) IF(IHC-F) IF(ICC)
Reactivity	Human, Mouse, Rat
Predicted Reactivity	Cow, Pig, Horse
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic phosphopeptide derived from human MCK10 around the phosphorylation site of Tyr513
Modification Site	Tyr513
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	780
Swiss Prot	Q08345
Subcellular location	Secreted, Cell membrane
Synonyms	MCK10 phospho Y513; p-MCK10 phospho Y513; CAK; CD167a; DDR1CD 167; CD167; Cell adhesion kinase; DDR 1; DDR; DDR1; Discoidin domain receptor; Discoidin receptor tyrosine kinase isoform a; EDDR 1; Epithelial discoidin domain receptor 1; Epithelial specic receptor kinase; Mammarian carcinoma kinase 10; Neuroepithelial tyrosine kinase; Neurotrophic tyrosine kinase receptor type 4; NTRK 4; PTK 3; PTK 3A protein tyrosine kinase 3A; Receptor tyrosine kinase NEP; RTK 6; TRK E; Tyrosine kinase receptor E; DDR1_HUMAN.
Background	Receptor tyrosine kinases (RTKs) play a key role in the communication of cells with their microenvironment. These molecules are involved in the regulation of cell growth, differentiation and metabolism. The protein encoded by this gene is a RTK that is widely expressed in normal and transformed epithelial cells and is activated by various types of collagen. This protein belongs to a subfamily of tyrosine kinase receptors with a homology region to the Dictyostelium discoideum protein discoidin I in their extracellular domain. Its autophosphorylation is achieved by all collagens so far tested (type I to type VI). In situ studies and Northern-blot analysis showed that expression of this encoded protein is restricted to epithelial cells, particularly in the kidney, lung, gastrointestinal tract, and brain. In addition, this protein is significantly over-expressed in several human tumors from breast, ovarian, esophageal, and pediatric brain. This gene is located on chromosome 6p21.3 in proximity to several HLA class I genes. Alternative splicing of this gene results in multiple transcript variants.
Application Dilution
WB	1:300-5000
ELISA	1:500-1000
IHC-P	1:200-400
IHC-F	1:100-500
IF(IHC-P)	1:50-200
IF(IHC-F)	1:50-200
IF(ICC)	1:50-200